Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men.

Leptin, the product of the ob gene, has been shown to increase heart rate and blood pressure through a stimulation of cardiac sympathetic nervous system activity, a phenomenon also involved in the pathogenesis of left ventricular hypertrophy in hypertensives. Thus, we hypothesize that plasma leptin concentration is associated with left ventricular hypertrophy. Forty hypertensive males and 15 healthy male subjects underwent anthropometric and echocardiographic evaluations, assessment of insulin sensitivity through euglycemic glucose clamp combined with indirect calorimetry, and determination of fasting plasma leptin concentration. Fasting plasma leptin levels were higher in hypertensives than in controls (6.48+/-2.9 versus 4. 62+/-1.5 ng/mL, P<0.05); these results were unchanged after adjustment for body mass index (P<0.05). In the whole group of patients (n=55), fasting plasma leptin concentration was correlated with body mass index (r=0.46, P<0.001) and waist/hip ratio (r=0.50, P<0.001); independent of body mass index and waist/hip ratio, fasting plasma leptin concentration was correlated (n=55) with whole-body glucose disposal (r=-0.27, P<0.04), interventricular septum thickness (r=0.34, P<0.001), posterior wall thickness (r=0.38, P<0.003), and the sum of wall thicknesses (r=0.68, P<0.001). In a multivariate analysis (n=55), age, body mass index, fasting plasma leptin concentration, plasma Na(+) concentration, whole-body glucose disposal, and diastolic blood pressure explained 68% of the variability of the sum of wall thicknesses with fasting plasma leptin concentration (P<0.03), whole body glucose disposal (P<0.002), and diastolic blood pressure (P<0.001), which were significantly and independently associated with the sum of wall thicknesses. In conclusion, our study demonstrates that fasting plasma leptin levels are associated with increased myocardial wall thickness independent of body composition and blood pressure levels in hypertensives.

[1]  R. Wing,et al.  Weight loss and leptin changes in individuals with type 2 diabetes. , 1999, Obesity research.

[2]  J. VanNess,et al.  Effects of central leptin administration on blood pressure in normotensive rats , 1998, Neuroscience Letters.

[3]  G. Steil,et al.  Physiological insulinemia acutely modulates plasma leptin. , 1998, Diabetes.

[4]  P. Deurenberg,et al.  Assessment of body composition. , 1998 .

[5]  J. Hall,et al.  Chronic leptin infusion increases arterial pressure. , 1998, Hypertension.

[6]  Huiqing Lu,et al.  Intracerebroventricular Leptin Increases Lumbar and Renal Sympathetic Nerve Activity and Blood Pressure in Normal Rats , 1997, Diabetes.

[7]  G. Paolisso,et al.  Myocardial wall thickness and left ventricular geometry in hypertensives. Relationship with insulin. , 1997, American journal of hypertension.

[8]  T Nakahata,et al.  Leptin stimulates the proliferation of murine myelocytic and primitive hematopoietic progenitor cells. , 1997, Blood.

[9]  K. Karason,et al.  Effects of obesity and weight loss on left ventricular mass and relative wall thickness: survey and intervention study , 1997, BMJ.

[10]  Y. Miyazaki,et al.  High plasma immunoreactive leptin level in essential hypertension. , 1997, American journal of hypertension.

[11]  A. Mark,et al.  Sympathetic and cardiorenal actions of leptin. , 1997, Hypertension.

[12]  A. Mark,et al.  Receptor-mediated regional sympathetic nerve activation by leptin. , 1997, The Journal of clinical investigation.

[13]  E. Ravussin,et al.  Relationship between muscle sympathetic nerve activity and plasma leptin concentration. , 1997, Obesity research.

[14]  K. Chihara,et al.  Leptin Induces Mitogen-activated Protein Kinase- dependent Proliferation of C3H10T1/2 Cells* , 1997, The Journal of Biological Chemistry.

[15]  R. Skoda,et al.  The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line. , 1997, Molecular endocrinology.

[16]  U. Stenman,et al.  Leptin synthesis is resistant to acute effects of insulin in insulin-dependent diabetes mellitus patients. , 1997, The Journal of clinical endocrinology and metabolism.

[17]  W. Alexander,et al.  Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  A. Ryan,et al.  The effects of acute hyperglycemia and hyperinsulinemia on plasma leptin levels: its relationships with body fat, visceral adiposity, and age in women. , 1996, The Journal of clinical endocrinology and metabolism.

[19]  E. Ravussin,et al.  Effects of acute hyperinsulinemia on plasma leptin concentrations in insulin-sensitive and insulin-resistant Pima Indians. , 1996, The Journal of clinical endocrinology and metabolism.

[20]  R. Leibel,et al.  Effects of gender, body composition, and menopause on plasma concentrations of leptin. , 1996, The Journal of clinical endocrinology and metabolism.

[21]  G. Reaven,et al.  Hypertension and associated metabolic abnormalities--the role of insulin resistance and the sympathoadrenal system. , 1996, The New England journal of medicine.

[22]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[23]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[24]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[25]  G. Paolisso,et al.  Effects of magnesium and nifedipine infusions on insulin action, substrate oxidation, and blood pressure in aged hypertensive patients. , 1993, American journal of hypertension.

[26]  C Cobelli,et al.  Glucose Transport in Human Skeletal Muscle: The In Vivo Response to Insulin , 1993, Diabetes.

[27]  D. Levy,et al.  Echocardiographic determinants of clinical outcome in subjects with coronary artery disease (the Framingham Heart Study). , 1992, The American journal of cardiology.

[28]  K. Nakajima,et al.  Long-term course and cardiac sympathetic nerve activity in patients with hypertrophic cardiomyopathy. , 1992, British heart journal.

[29]  P. Deurenberg,et al.  Assessment of body composition by bioelectrical impedance in a population aged greater than 60 y. , 1990, The American journal of clinical nutrition.

[30]  E. Ferrannini.  The theoretical bases of indirect calorimetry: a review. , 1988, Metabolism: clinical and experimental.

[31]  D. Levy,et al.  Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. , 1987, The American journal of cardiology.

[32]  R. DeFronzo,et al.  Regulation of Splanchnic and Peripheral Glucose Uptake by Insulin and Hyperglycemia in Man , 1983, Diabetes.

[33]  M. Safar,et al.  Echocardiographic dimensions in borderline and sustained hypertension. , 1979, The American journal of cardiology.

[34]  R. DeFronzo,et al.  Glucose clamp technique: a method for quantifying insulin secretion and resistance. , 1979, The American journal of physiology.

[35]  A. DeMaria,et al.  Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.

[36]  N Reichek,et al.  Echocardiographic Determination of Left Ventricular Mass in Man: Anatomic Validation of the Method , 1977, Circulation.